Page 73 - 2021年19期
P. 73

多西紫杉醇-双氢青蒿素偶联前药自组装纳米粒的稳定性、体外

        释放特征及组织分布                       Δ


              *
        李玉洁 ,李 宁,王蓉蓉,张淑秋,任国莲(山西医科大学药学院,山西 晋中 030619)
                                             #
        中图分类号 R917;R965          文献标志码 A          文章编号     1001-0408(2021)19-2371-07
        DOI  10.6039/j.issn.1001-0408.2021.19.11

        摘  要   目的:研究多西紫杉醇(DTX)-双氢青蒿素(DHA)偶联前药自组装纳米粒(DTX-S-S-DHA NPs)的稳定性、体外释放特征
        及组织分布。方法:采用高效液相色谱法进行DTX-S-S-DHA的体外分析;以粒径、多分散系数(PDI)和包封率(EE)为评价指标,
        考察DTX-S-S-DHA NPs在不同介质[水、生理盐水、磷酸盐缓冲液(PBS,pH 7.4)和RPMI 1640培养基]中的物理稳定性和长期稳定
        性;以含或不含10 mmol/L二硫苏糖醇(DTT)的30%乙醇溶液为释放介质,采用小杯法考察DTX-S-S-DHA NPs中DTX-S-S-DHA
        的体外释放特征;采用小动物活体成像仪考察经DiR染料标记的DTX-S-S-DHA NPs(DTX-S-S-DHA/DiR NPs)在乳腺癌荷瘤模型
        小鼠组织中的分布以及肿瘤靶向性。结果:在稳定性实验中,DTX-S-S-DHA NPs在水、生理盐水、PBS、RPMI 1640培养基中振荡
        24 h内,其粒径、PDI、EE均无明显变化;在4 ℃条件下保存时,随着保存时间的增加,其在生理盐水中的粒径逐渐增大,在PBS中
        的粒径逐渐减小,且在两者中的EE逐渐降低至75%以下,而在水和RPMI 1640培养基中的粒径、PDI、EE均无明显变化。在体外
        释放实验中,DTX-S-S-DHA NPs 中的 DTX-S-S-DHA 在含 10 mmol/L DTT 的释放介质中基本不释放;而在不含 DTT 的释放介质
        中,其 24 h 累积释放率可达 83%,符合一级动力学模型释放特征。在组织分布实验中,DTX-S-S-DHA/DiR NPs 在小鼠肿瘤组
        织中的分布明显多于其他组织(心、肝、脾、肺、肾)。结论:DTX-S-S-DHA NPs在不同介质中均具有良好的物理稳定性,且在水和
        RPMI 1640培养基中具有良好的长期稳定性;其在还原环境中能迅速释放出母药,具有很好的肿瘤靶向性。
        关键词 多西紫杉醇;双氢青蒿素;偶联前药;自组装纳米粒;稳定性;体外释放;组织分布

        Stability,in vitro Release and Tissue Distribution of Docetaxel-dihydroartemisinin Conjugated Prodrug
        Self-assembled Nanoparticles
        LI Yujie,LI Ning,WANG Rongrong,ZHANG Shuqiu,REN Guolian(School of Pharmacy,Shanxi Medical
        University,Shanxi Jinzhong 030619,China)
        ABSTRACT    OBJECTIVE:To study the stability,in vivo release characteristics and tissue distribution of docetaxel(DTX)-
        dihydroartemisinin (DHA) conjugated prodrug self-assembled nanoparticles (DTX-S-S-DHA NPs). METHODS:HPLC method
        was adopted to analyze DTX-S-S-DHA in vitro. The phycial and long-term stability of DTX-S-S-DHA NPs in mediums [water,
        saline,phosphate buffer(PBS,pH 7.4)and RPMI 1640 medium] were investigated by using particle size,polydispersity index
       (PDI)and encapsulation efficiency(EE)as evaluation indexes. The in vitro release characteristics of DTX-S-S-DHA released from
        DTX-S-S-DHA NPs was also investigated with small glass method,using 30% ethanol solution with or without 10 mmol/L
        dithiothreitol(DTT)as medium. The small live animal imager was adopted to investigate the tissue distribution and tumor targeting
        capability of DiR-labeled DTX-S-S-DHA NPs (DTX-S-S-DHA/DiR NPs)in breast cancer bearing mice. RESULTS:In stability
        test,there was no statistical difference in particle size,PDI and EE of DTX-S-S-DHA NPs incubated in water,normal saline,PBS
        and RPMI 1640 medium for 24 h. When stored at 4 ℃,with the increase of storage time,the particle size of DTX-S-S-DHA NPs
        in normal saline gradually increased,while those in PBS gradually decreased;EE of both gradually decreased to less than 75%,
        but there was no significant change in particle size,PDI and EE of DTX-S-S-DHA NPs in water and RPMI 1640 medium. In the in
        vitro release experiments,DTX-S-S-DHA in DTX-S-S-DHA NPs was not released in the release medium containing 10 mmol/L
        DTT;at 24 h,the cumulative release rate of DTX-S-S-DHA released from DTX-S-S-DHA NPs in release medium without DTT
        was about 83%,which was in line with first-order kinetic model. In tissue distribution test,the distribution of DTX-S-S-DHA/DiR
        NPs in tumor sites of mice was significantly more than in other tissues(heart,liver,spleen,lung and kidney). CONCLUSIONS:
        DTX-S-S-DHA NPs show good physical stability in different mediums,especially have good long-term stability in water and RPMI
                                                           1640 medium;they can quickly release the parent drug in the
           Δ 基金项目:山西省平台基地和人才专项(No.201805D211002);
        山西医科大学博士启动基金资助项目(No.03201619)                      reduction environment and has good tumor targeting.
           * 硕 士 研 究 生 。 研 究 方 向 :新 剂 型 与 药 动 学 。 电 话 :0351-  KEYWORDS   Docetaxel; Dihydroartemisinin; Conjugated
        3985243。E-mail:13603122995@163.com                 prodrug;Self-assembled nanoparticles; Stability; in vitro
           # 通信作者:副教授,硕士生导师,博士。研究方向:小分子抗肿                  release;Tissue distribution
        瘤药物新型纳米递药系统。电话:0351-3985190。E-mail:glren2007@
        126.com


        中国药房    2021年第32卷第19期                                             China Pharmacy 2021 Vol. 32 No. 19  ·2371 ·
   68   69   70   71   72   73   74   75   76   77   78